Happy Saturday! Or maybe not so happy if you’re dealing with the weight struggles that some of our readers are writing in about this week. Got the dieting blues? We hear you. Please take a gander at this week’s edition of Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
Debbie from Washington, type 2, writes: I’ve had diabetes…
Welcome back to our Saturday diabetes advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois — where myths get busted and unseemly topics sometimes see the light of day. Hey, where else ya gonna turn?
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
First things first this week:
Exercising over 250 mg/dL CORRECTION:
Last week we talked about how it’s generally considered unsafe to start…
As we all know, there’s A LOT to remember when it comes to diabetes. So Timesulin, a virtual company founded in 2009 in Germany, Sweden and the UK, hopes to help patients remember whether or not they’ve taken their insulin injection.
Unlike insulin pumps, most insulin pens don’t come with a memory that you can scroll through to check whether or not you already bolused for your dinner. What to do if you’re unsure? Not taking…
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
Health professionals reportedly are receiving letters this week alerting them to an FDA warning just issued about risks of thyroid cancer and pancreatitis associated with the popular type 2 diabetes drug liraglutide (Victoza). Yikes!
According to MSM reports, the evidence was found in mice, and it’s unclear if the serious risks translate to humans — but there was enough concern to issue the follow warning:
“Clinical trials have shown more cases of pancreatitis with liraglutide…